IBRN
iShares Neuroscience and Healthcare ETF · PSE
- Category Equity
- Expense Ratio 0.47%
- Listing Date Aug 26, 2022
- Volume 47.0
- Market Cap (AUM) $3.49M
Performance
-2.98%
1W
-6.3%
1M
-10.18%
3M
+18.04%
6M
-11.27%
YTD
-11.77%
1Y
Top Holdings
-
Name
Symbol%Assets
- Neurocrine Biosciences, Inc.NBIX4.98%
- PTC Therapeutics, Inc.PTCT4.89%
- Cerevel Therapeutics Holdings IncCERE4.75%
- Intra-Cellular Therapies, Inc.ITCI4.66%
- Sarepta Therapeutics, Inc.SRPT4.66%
- Axonics, Inc.AXNX4.52%
- Biogen Inc.BIIB4.48%
- argenx SE ADRARGX4.46%
- Xenon Pharmaceuticals Inc.XENE4.15%
- Biohaven Ltd.BHVN3.71%
Technical Analysis of IBRN 2024-05-10
Overview:
In analyzing the technical indicators for IBRN over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key indicators, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysi...
Recent News & Updates
Page 1 of 1
previousnext